ReviewCancers2026

Metabolic Reprogramming in Bladder Cancer: Molecular Drivers, Immune Regulation and Therapeutic Opportunities.

Shaolin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.